Item Infomation


Title: Evolution of treatment patterns and survival outcomes in patients with advanced non-small cell lung cancer treated at Frankfurt University Hospital in 2012–2018
Authors: Andrea, Wolf
Jan A., Stratmann
Shabnam, Shaid
Issue Date: 2023
Publisher: Springer
Abstract: Immune checkpoint inhibitors (ICIs) have improved outcomes for patients with advanced non-small cell lung cancer (NSCLC) versus chemotherapy in clinical trials. In Germany, ICIs have been used clinically since 2015 for patients with advanced/metastatic NSCLC without epidermal growth factor receptor (EGFR)/anaplastic lymphoma kinase (ALK) aberrations. As part of I-O Optimise, a multinational research program utilizing real-world data on thoracic malignancies, we describe real-world treatment patterns and survival following reimbursement of ICIs for advanced NSCLC in Germany.
Description: CC BY
URI: https://link.springer.com/article/10.1186/s12890-022-02288-1
https://dlib.phenikaa-uni.edu.vn/handle/PNK/7262
Appears in CollectionsOER- Y học- Điều dưỡng
ABSTRACTS VIEWS

55

FULLTEXT VIEWS

72

Files in This Item: